This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Iterion Therapeutics, Inc., Other. Active years: 2022-2025.
Company Filing History:
1 out of 9 
2 out of 834,307 Years Active: 2022-2025
Title: The Innovations of Stephen Horrigan
Introduction
Stephen Horrigan is an accomplished inventor based in Houston, TX. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various medical conditions. With a total of three patents to his name, Horrigan's work has the potential to impact many lives.
Latest Patents
Horrigan's latest patents include formulations of tegavivint and related compounds. These patents detail methods of making such formulations and methods of treating various conditions utilizing these formulations. Additionally, he has developed methods for the treatment of fibrotic diseases using compounds of a specific formula.
Career Highlights
Throughout his career, Horrigan has worked with Iterion Therapeutics, Inc., where he has been instrumental in advancing innovative treatments. His expertise in pharmaceutical formulations has positioned him as a key figure in his field.
Collaborations
Horrigan has collaborated with notable professionals, including Jeffrey Scott Larson and Steven David Dykstra. These partnerships have further enhanced his research and development efforts.
Conclusion
Stephen Horrigan's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to innovation and improving medical treatments. His work continues to pave the way for advancements in healthcare.